Naturally occurring autoantibodies against β-amyloid

Investigating their role in transgenic animal and in vitro models of Alzheimer's disease

Richard Dodel, Karthikeyan Balakrishnan, Kathy Keyvani, Oliver Deuster, Frauke Neff, Luminita Cornelia Andrei-Selmer, Stephan Röskam, Carsten Stüer, Yousef Al-Abed, Carmen Noelker, Monika Balzer-Geldsetzer, Wolfgang Oertel, Yansheng Du, Michael Bacher

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain responsible for higher cognitive functions. Immunization against β-amyloid (Aβ) in animal models of AD has been shown to be effective on the molecular level but also on the behavioral level. Recently, we reported naturally occurring autoantibodies against Aβ (NAbs-Aβ) being reduced in Alzheimer's disease patients. Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Aβ recognized the mid-/C-terminal end of Aβ and preferentially bound to oligomers but failed to bind to monomers/fibrils. NAbs-Aβ were able to interfere with Aβ peptide toxicity, but NAbs-Aβ did not readily clear senile plaques although early fleecy-like plaques were reduced. Administration of NAbs-Aβ in transgenic mice improved the object location memory significantly, almost reaching performance levels of wild-type control mice. These findings suggest a novel physiological mechanism involving NAbs-Aβ to dispose of proteins or peptides that are prone to forming toxic aggregates.

Original languageEnglish
Pages (from-to)5847-5854
Number of pages8
JournalJournal of Neuroscience
Volume31
Issue number15
DOIs
StatePublished - Apr 13 2011

Fingerprint

Genetically Modified Animals
Amyloid
Autoantibodies
Alzheimer Disease
Epitope Mapping
Peptides
Poisons
Amyloid Plaques
Neurodegenerative Diseases
Cognition
Transgenic Mice
In Vitro Techniques
Immunization
Animal Models
Brain
Proteins

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Naturally occurring autoantibodies against β-amyloid : Investigating their role in transgenic animal and in vitro models of Alzheimer's disease. / Dodel, Richard; Balakrishnan, Karthikeyan; Keyvani, Kathy; Deuster, Oliver; Neff, Frauke; Andrei-Selmer, Luminita Cornelia; Röskam, Stephan; Stüer, Carsten; Al-Abed, Yousef; Noelker, Carmen; Balzer-Geldsetzer, Monika; Oertel, Wolfgang; Du, Yansheng; Bacher, Michael.

In: Journal of Neuroscience, Vol. 31, No. 15, 13.04.2011, p. 5847-5854.

Research output: Contribution to journalArticle

Dodel, R, Balakrishnan, K, Keyvani, K, Deuster, O, Neff, F, Andrei-Selmer, LC, Röskam, S, Stüer, C, Al-Abed, Y, Noelker, C, Balzer-Geldsetzer, M, Oertel, W, Du, Y & Bacher, M 2011, 'Naturally occurring autoantibodies against β-amyloid: Investigating their role in transgenic animal and in vitro models of Alzheimer's disease', Journal of Neuroscience, vol. 31, no. 15, pp. 5847-5854. https://doi.org/10.1523/JNEUROSCI.4401-10.2011
Dodel, Richard ; Balakrishnan, Karthikeyan ; Keyvani, Kathy ; Deuster, Oliver ; Neff, Frauke ; Andrei-Selmer, Luminita Cornelia ; Röskam, Stephan ; Stüer, Carsten ; Al-Abed, Yousef ; Noelker, Carmen ; Balzer-Geldsetzer, Monika ; Oertel, Wolfgang ; Du, Yansheng ; Bacher, Michael. / Naturally occurring autoantibodies against β-amyloid : Investigating their role in transgenic animal and in vitro models of Alzheimer's disease. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 15. pp. 5847-5854.
@article{359641d436f74f1094f269bc0cc685e5,
title = "Naturally occurring autoantibodies against β-amyloid: Investigating their role in transgenic animal and in vitro models of Alzheimer's disease",
abstract = "Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain responsible for higher cognitive functions. Immunization against β-amyloid (Aβ) in animal models of AD has been shown to be effective on the molecular level but also on the behavioral level. Recently, we reported naturally occurring autoantibodies against Aβ (NAbs-Aβ) being reduced in Alzheimer's disease patients. Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Aβ recognized the mid-/C-terminal end of Aβ and preferentially bound to oligomers but failed to bind to monomers/fibrils. NAbs-Aβ were able to interfere with Aβ peptide toxicity, but NAbs-Aβ did not readily clear senile plaques although early fleecy-like plaques were reduced. Administration of NAbs-Aβ in transgenic mice improved the object location memory significantly, almost reaching performance levels of wild-type control mice. These findings suggest a novel physiological mechanism involving NAbs-Aβ to dispose of proteins or peptides that are prone to forming toxic aggregates.",
author = "Richard Dodel and Karthikeyan Balakrishnan and Kathy Keyvani and Oliver Deuster and Frauke Neff and Andrei-Selmer, {Luminita Cornelia} and Stephan R{\"o}skam and Carsten St{\"u}er and Yousef Al-Abed and Carmen Noelker and Monika Balzer-Geldsetzer and Wolfgang Oertel and Yansheng Du and Michael Bacher",
year = "2011",
month = "4",
day = "13",
doi = "10.1523/JNEUROSCI.4401-10.2011",
language = "English",
volume = "31",
pages = "5847--5854",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "15",

}

TY - JOUR

T1 - Naturally occurring autoantibodies against β-amyloid

T2 - Investigating their role in transgenic animal and in vitro models of Alzheimer's disease

AU - Dodel, Richard

AU - Balakrishnan, Karthikeyan

AU - Keyvani, Kathy

AU - Deuster, Oliver

AU - Neff, Frauke

AU - Andrei-Selmer, Luminita Cornelia

AU - Röskam, Stephan

AU - Stüer, Carsten

AU - Al-Abed, Yousef

AU - Noelker, Carmen

AU - Balzer-Geldsetzer, Monika

AU - Oertel, Wolfgang

AU - Du, Yansheng

AU - Bacher, Michael

PY - 2011/4/13

Y1 - 2011/4/13

N2 - Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain responsible for higher cognitive functions. Immunization against β-amyloid (Aβ) in animal models of AD has been shown to be effective on the molecular level but also on the behavioral level. Recently, we reported naturally occurring autoantibodies against Aβ (NAbs-Aβ) being reduced in Alzheimer's disease patients. Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Aβ recognized the mid-/C-terminal end of Aβ and preferentially bound to oligomers but failed to bind to monomers/fibrils. NAbs-Aβ were able to interfere with Aβ peptide toxicity, but NAbs-Aβ did not readily clear senile plaques although early fleecy-like plaques were reduced. Administration of NAbs-Aβ in transgenic mice improved the object location memory significantly, almost reaching performance levels of wild-type control mice. These findings suggest a novel physiological mechanism involving NAbs-Aβ to dispose of proteins or peptides that are prone to forming toxic aggregates.

AB - Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain responsible for higher cognitive functions. Immunization against β-amyloid (Aβ) in animal models of AD has been shown to be effective on the molecular level but also on the behavioral level. Recently, we reported naturally occurring autoantibodies against Aβ (NAbs-Aβ) being reduced in Alzheimer's disease patients. Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Aβ recognized the mid-/C-terminal end of Aβ and preferentially bound to oligomers but failed to bind to monomers/fibrils. NAbs-Aβ were able to interfere with Aβ peptide toxicity, but NAbs-Aβ did not readily clear senile plaques although early fleecy-like plaques were reduced. Administration of NAbs-Aβ in transgenic mice improved the object location memory significantly, almost reaching performance levels of wild-type control mice. These findings suggest a novel physiological mechanism involving NAbs-Aβ to dispose of proteins or peptides that are prone to forming toxic aggregates.

UR - http://www.scopus.com/inward/record.url?scp=79955758133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955758133&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4401-10.2011

DO - 10.1523/JNEUROSCI.4401-10.2011

M3 - Article

VL - 31

SP - 5847

EP - 5854

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 15

ER -